Trends surrounding Big Data, enhanced collaboration between healthcare players and consumers as well as data for secondary use will continue to play an important role in life sciences field
Now more than ever, companies are recognizing the necessity of connectivity and interoperability for success within the pharmaceutical industry. The following are life sciences trends that will continue to affect the pharmaceutical market for the remainder of 2013:
1. Big Data will play an even bigger role in supporting a pharmaceutical company’s bottom line.
Pharmaceutical companies can create actionable information out of Big Data in order to support their organization’s bottom line. By aggregating and harmonizing critical patient information in a platform such as a clinical data repository, companies have a better gauge of where to allocate research and development dollars, increase speed-to-market and support the organization’s financial success. This trend will continue to play a big role in the pharmaceutical industry in 2013 as more companies adopt cloud-based services as the primary method that can quickly and easily store, manage and provide access Big Data.
2. Enhanced collaboration between pharmaceutical companies, partners, providers and consumers is necessary to move the industry forward.
Many pharmaceutical companies already keep databases with information on pharmacies they sell to and what drugs are needed in the market. However, enhanced collaboration with other players such as providers, clinical research organizations, labs and consumers will help back-office processes to benefit all players affected by the pharmaceutical industry. The time is now for pharmaceutical companies to access platforms that can collect this structured and unstructured patient information and make it available in a variety of views and formats for enhanced partnership and collaboration.
3. Access to data for secondary use can improve patient care and overall population health management.
Collaboration between players in the healthcare and pharmaceutical industry is critical, but even more important is the exchange of patient information for secondary use. In order to enhance care coordination, the exchange of information between both entities can improve clinical trials, provide more information on where to allocate research and development money, increase speed-to-market and better monitor population health for improved patient outcomes. In the second half of 2013, pharmaceutical companies that have access to real-time data exchange will continue to prove their success within the industry.
“The pharmaceutical industry will continue to recognize the growing need for connectivity and interoperability within the four walls of an organization and beyond,” said Gary Palgon, vice president, healthcare solutions, Liaison Healthcare. “Cloud-based services along with Big Data management can help your organization align with these growing trends, taking work off your plate by solving your complex data challenges and moving you forward, this year and in the years to come.”
To learn more about Liaison Healthcare, visit www.liaisonhealthcare.com.
For more information:
About Liaison Healthcare
Liaison Healthcare Informatics is a global data integration, harmonization and management company, serving more than 1200 customers within healthcare and life science industries. Utilizing customized cloud-based solutions; Liaison helps health systems, hospitals, and clinicians, HIEs, Laboratories, pharmaceutical and biotech companies quickly secure meaningful use from a wide variety of health information. By connecting healthcare entities and harmonizing complex and disparate data, Liaison Healthcare’s solutions contribute directly to the improvement of patient-care coordination. Our customized solutions provide increased overall efficiency and faster time-to-market for all types of healthcare organizations. For more information, visit www.liaisonhealthcare.com or call 877.336.5163.
Liaison Technologies is a global data management and integration company. It provides innovative solutions to integrate, transform, harmonize, manage and secure critical business data on-premise or in the cloud. With a comprehensive array of business-to-business and application-to-application integration and data transformation services, as well as on-premise and cloud-based data security solutions, Liaison’s practitioners implement data management infrastructures adapted to each client’s specific business requirements. Headquartered in Atlanta, Liaison has offices in the Netherlands, Finland, Sweden and the United Kingdom. For more information, visit liaison.opentext.com.
Liaison and the Liaison logo are trademarks of Liaison Technologies, Inc. All other names or product names mentioned in this release are trademarks or registered trademarks of their respective companies.